RxDoctor Payments Data

Isaac Cohen, MD

Pain Medicine · Trumbull, CTNPI 1629005350

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,165 of the $1,502 with a category attached, or 77.5%. 13 manufacturers reported payments, led by Pacira Pharmaceuticals Incorporated at 43.0% of the total. Reporting peaked in 2022 at $764 and has fallen 77.1% since, to $175 in 2025. That places this record below the midpoint for pain medicine clinicians in CT, where the typical reported total is $2,061.

$1,502in general payments, 2019–2025

Across 34 payments — averaging $44.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pacira Pharmaceuticals Incorporated$645
  • SPR Therapeutics, Inc$317
  • Johnson & Johnson$187
  • Abbott$96
  • Vertex$63
  • Pacira Therapeutics, Inc.$38
  • plus $156 from 7 others

What the payments were for

  • Travel & lodging$33722%
  • Food & beverage$1,16578%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,502 in reported general payments places this provider in the 40th percentile of 69 pain medicine providers in Connecticut.

See all pain medicine providers in Connecticut

Medicare billing

Part B allowed, 2024
$136,692
Medicare patients
290
Services billed
2,704

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin301$3,418
Lidocaine15$1,519
Pregabalin84$1,212
Tramadol Hcl150$956
Cyclobenzaprine Hcl31$392
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen15$241
Tizanidine Hcl11$186
Celecoxib11$181
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen11$120
Methylprednisolone11$71
Alprazolam47$42

Paid to pharmacies, not to this prescriber.

Other pain medicine in Trumbull

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →